Paxlovid slashed risk of COVID hospital stay in unvaccinated patients -- Canadian study

Paxlovid slashed risk of COVID hospital stay in some patients amid Omicron, study suggests CIDRAP

The antiviral drug Paxlovid was tied to a 96% lower relative risk (RR) of COVID-19 hospitalization among high-risk outpatients who didn't complete a primary vaccination series but didn't benefit those who had received at least two doses amid the SARS-CoV-2 Omicron variant, according to a real-world study published yesterday in Clinical Infectious Diseases.

....